1. Home
  2. CVAC vs BTBT Comparison

CVAC vs BTBT Comparison

Compare CVAC & BTBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • BTBT
  • Stock Information
  • Founded
  • CVAC 2000
  • BTBT 2015
  • Country
  • CVAC Germany
  • BTBT United States
  • Employees
  • CVAC N/A
  • BTBT N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • BTBT Finance: Consumer Services
  • Sector
  • CVAC Health Care
  • BTBT Finance
  • Exchange
  • CVAC Nasdaq
  • BTBT Nasdaq
  • Market Cap
  • CVAC 1.2B
  • BTBT 1.1B
  • IPO Year
  • CVAC 2020
  • BTBT 2018
  • Fundamental
  • Price
  • CVAC $5.35
  • BTBT $2.96
  • Analyst Decision
  • CVAC Hold
  • BTBT Strong Buy
  • Analyst Count
  • CVAC 3
  • BTBT 3
  • Target Price
  • CVAC $6.83
  • BTBT $6.33
  • AVG Volume (30 Days)
  • CVAC 471.1K
  • BTBT 21.4M
  • Earning Date
  • CVAC 11-11-2025
  • BTBT 08-14-2025
  • Dividend Yield
  • CVAC N/A
  • BTBT N/A
  • EPS Growth
  • CVAC N/A
  • BTBT N/A
  • EPS
  • CVAC 1.01
  • BTBT N/A
  • Revenue
  • CVAC $599,540,810.00
  • BTBT $98,402,256.00
  • Revenue This Year
  • CVAC N/A
  • BTBT $16.34
  • Revenue Next Year
  • CVAC $23.95
  • BTBT $44.80
  • P/E Ratio
  • CVAC $5.32
  • BTBT N/A
  • Revenue Growth
  • CVAC 675.15
  • BTBT 13.30
  • 52 Week Low
  • CVAC $2.37
  • BTBT $1.69
  • 52 Week High
  • CVAC $5.72
  • BTBT $5.74
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 44.43
  • BTBT 55.42
  • Support Level
  • CVAC $5.32
  • BTBT $2.86
  • Resistance Level
  • CVAC $5.41
  • BTBT $3.16
  • Average True Range (ATR)
  • CVAC 0.04
  • BTBT 0.17
  • MACD
  • CVAC -0.01
  • BTBT 0.05
  • Stochastic Oscillator
  • CVAC 33.33
  • BTBT 73.47

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About BTBT Bit Digital Inc.

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.

Share on Social Networks: